Christine A. Szekely, Ph.D.
Affiliations: | 2006 | Johns Hopkins University, Baltimore, MD |
Area:
Public Health, Mental Health, PharmacologyGoogle:
"Christine Szekely"Cross-listing: PHTree
Parents
Sign in to add mentor| Curtis Meinert | grad student | 2006 | Johns Hopkins | |
| (Non -steroidal anti -inflammatory drugs and the risk of Alzheimer's disease.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cohen RM, Rezai-Zadeh K, Weitz TM, et al. (2013) A transgenic Alzheimer rat with plaques, tau pathology, behavioral impairment, oligomeric aβ, and frank neuronal loss. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 6245-56 |
| Szekely CA, Zandi PP. (2010) Non-steroidal anti-inflammatory drugs and Alzheimer's disease: The epidemiological evidence Cns and Neurological Disorders - Drug Targets. 9: 132-139 |
| Rezai-Zadeh K, Gate D, Szekely CA, et al. (2009) Can peripheral leukocytes be used as Alzheimer's disease biomarkers? Expert Review of Neurotherapeutics. 9: 1623-33 |
| Fotuhi M, Zandi PP, Hayden KM, et al. (2008) Better cognitive performance in elderly taking antioxidant vitamins E and C supplements in combination with nonsteroidal anti-inflammatory drugs: the Cache County Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 223-7 |
| Town T, Laouar Y, Pittenger C, et al. (2008) Blocking TGF-beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nature Medicine. 14: 681-7 |
| Szekely CA, Green RC, Breitner JC, et al. (2008) No advantage of A beta 42-lowering NSAIDs for prevention of Alzheimer dementia in six pooled cohort studies. Neurology. 70: 2291-8 |
| Lyketsos CG, Szekely CA, Mielke MM, et al. (2008) Developing new treatments for Alzheimer's disease: the who, what, when, and how of biomarker-guided therapies. International Psychogeriatrics / Ipa. 20: 871-89 |
| Martin BK, Szekely C, et al. (2008) Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Archives of Neurology. 65: 896-905 |
| Szekely CA, Breitner JC, Fitzpatrick AL, et al. (2008) NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type. Neurology. 70: 17-24 |
| Szekely CA, Breitner JC, Zandi PP. (2007) Prevention of Alzheimer's disease. International Review of Psychiatry (Abingdon, England). 19: 693-706 |